Major histocompatibility complex class II antigen expression in rejecting cardiac allografts: Detection using in vivo imaging with radiolabeled monoclonal antibody

Circulation

Volumn 96, Issue 5, 1997, Pages 1605-1611

  McGhie, A Iain ^a   Radovancevic, Branislav ^b   Capek, Pavel ^b   Moore, Warren H ^c   Kasi, Leela ^d   Lamki, Lamk ^a   Clubb Jr , Fred J ^b   Frazier, O Howard ^a,b   Willerson, James T ^a,b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b ST LUKE S EPISCOPAL HOSPITAL   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d Department of Internal Medicine ^*

Author keywords

Imaging; Immunology; Radioisotopes; Rejection; Transplantation

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; DOG; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; ISOTOPE LABELING; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL;

EID: 0030776738     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.5.1605     Document Type: Article

References (24)

1. Kriett JM, Kaye MP. The registry of the International Society for Heart and Lung Transplantation: eighth official report-1991. J Heart Lung Transplant. 1991;10:491-498.
2. Rose AG. Endomyocardial biopsy diagnosis for cardiac rejection. Heart Failure. 1986;2:64-72.
3. O'Connell JB, Bourge RC, Costanzo-Nordin MR, Driscoll DJ, Morgan JP, Rose EA, Uretsky BF. Cardiac transplantation: recipient selection, donor procurement, and medical follow-up. Circulation. 1992;86:1061-1079.
4. Billingham ME. Dilemma of variety of histopathologic grading systems of acute cardiac allograft rejection by endomyocardial biopsy. J Heart Transplant. 1990;9:272-276.
5. Rose ML, Coles MI, Griffin RJ, Pomerance A, Yacoub MH. Expression of class I and class II major histocompatibility antigens in normal and transplanted human heart. Transplantation. 1986;41: 776-780.
6. Carlquist JF, Hammond E, Yowell RL, O'Connell JB, Anderson JL. Correlation between class II antigen (DR) expression and interleukin-2-induced lymphocyte proliferation during the acute cardiac allograft rejection. Transplantation. 1990;50:582-588.
7. Isobe M, Narula J, Southern JF, Strauss HW, Khaw BA, Haber E. Imaging the rejecting heart: in vivo detection of major histocompatibility complex class II antigen induction. Circulation. 1992;85: 738-746.
8. Strepkowski S, Raza-Ahmad A, Duncan W. The role of class I and class II MHC antigens in the rejection of vascularized heart allografts in mice. Transplantation. 1987;44:753-759.
9. Carrel A, Guthrie CC. The transplantation of veins and organs. Am J Med. 1905;10:1101-1102.
10. McAllister HA. Histologic grading of cardiac allograft rejection: a quantitative approach. J Heart Transplant. 1990;9:277-282.
11. Billingham ME, Cary NR, Hammond ME, Kemnitz J, Marboe C, McCallister HA, Snovar DC, Winters GL, Zerbe A. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: heart rejection study group. J Heart Transplant. 1990;9:5887-5893.
12. Davis WC, Marusic S, Lewin HA, Splitter GA, Ferryman LE, McGuire TC, Gorham JR. The development and analysis of species specific and cross reactive monoclonal antibodies to leukocyte differentiation antigens and antigens of the major histocompatibility complex for use in the study of the immune system in cattle and other species. Vet Immunol Immunopathol. 1987;15:337-376.
13. Ababou A, Goyeneche J, Davis WC, Levy D. Evidence for the expression of three different BoLA-class II molecules on the bovine BL-3 cell line: determination of a non-DR non-DQ gene product. J Leukoc Biol. 1994;56:182-186.
14. Ababou A, Davis WC, Levy D. The DA6-147 monoclonal antibody raised against the HLA-DRa chain identifies a cryptic epitope on the BoLA-DRa chain. Ann Rech Vet. 1993;24:402-407.
15. Fraker PJ, Speck JC. Protein and cell membrane iodinations with a sparingly soluble chloroamide 1,3,4,6-tetrachloro-3α,6α,-diphenylglycouril. Biochem Biophys Res Commun. 1978;80:849-857.
16. Hnatowich DJ, Childs RL, Lantaigne D, Najafi A. The preparation of DTPA-coupled antibodies radiolabeled with metallic radionuclides: an improved method. J Immunol Methods. 1983;65:147-157.
17. Hall TS, Baumgarter WA, Borkon AM, LaFrance ND, Triall TA, Norris S, Hutchins GM, Brawn J, Reitz BA. Diagnosis of acute cardiac rejection with antimyosin monoclonal antibody, phosphorous nuclear magnetic resonance imaging, two-dimensional echocardiography, and endocardial biopsy. J Heart Transplant. 1986;5:419-424.
18. Addonizio LJ, Michler RE, Marboe C, Esser PE, Johnson LL, Seldin DW, Gersony WM, Alderson PO, Rose EA, Cannon PJ. Imaging of cardiac allograft rejection in dogs using indium-111 monoclonal antimyosin Fab. J Am Coll Cardiol. 1987;9:555-564.
19. 111In antimyosin imaging in mouse heart allografts. Circulation. 1991;84:1246-1255.
20. Takeda K, Ueda K, Scheffel U, Ravert H, LaFrance D, Baumgartner WA, Reaitz BA, Herslowitz A, Wagner HN. Indium-111 myosin-specific antibodies and technetium-99m pyrophosphate in the detection of acute cardiac rejection of transplanted hearts: studies in a heterotopic heart model. Eur J Nucl Med. 1991;18:461-466.
21. Frist W, Yasuda T, Segall G, Khaw BA, Strauss HW, Gold H, Stinson E, Oyer P, Baldwin J, Billingham M, McDougall IR, Haber E. Noninvasive detection of human cardiac transplant rejection with indium-111 antimyosin (Fab) imaging. Circulation. 1987; 76(suppl V):V-81-V-85.
22. Ballester M, Obrador D, Carrio I, Moya C, Auge JM, Bordes R, Marti V, Bosch I, Berna-Roqueta L, Estorch M, Pons-Llado G, Camara ML, Padro JM, Aris A, Caralps-Riera JM. Early postoperative reduction of monoclonal antimyosin antibody uptake is associated with absent rejection-related complications after heart transplantation. Circulation. 1992;85:61-68.
23. Conti DJ, Andersen R, Soper WD, Wolf JS. Comparison of clinical response of DR-matched, MLC-compatible cadaver renal allografts and those from HLA-identical twins. Transplant Proc. 1987;19: 652-654.
24. Kerman RH, Van Bueren CT, Lewis RM, Frazier OH, Cooley D, Kahan BD. The impact of HLA A, B, and DR blood transfusions and immune receptor status on cardiac allograft recipients treated with cyclosporine. Transplant. 1988;45:333-337.